Clinical Trial Update: Using ctDNA to Guide Treatment Decisions for Stage III Gastric Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial in stage III gastric cancer is evaluating whether circulating tumor DNA (ctDNA) can guide treatment decisions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Gastric Cancer Stage III | Phase 3 | Status: ACTIVE_NOT_RECRUITING